X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA PFIZER NATCO PHARMA/
PFIZER
 
P/E (TTM) x 32.7 25.0 130.7% View Chart
P/BV x 16.6 4.0 418.4% View Chart
Dividend Yield % 0.7 0.8 84.4%  

Financials

 NATCO PHARMA   PFIZER
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
PFIZER
Mar-16
NATCO PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs8772,724 32.2%   
Low Rs4241,611 26.3%   
Sales per share (Unadj.) Rs223.4440.9 50.7%  
Earnings per share (Unadj.) Rs31.148.7 63.8%  
Cash flow per share (Unadj.) Rs40.375.8 53.2%  
Dividends per share (Unadj.) Rs5.0015.00 33.3%  
Dividend yield (eoy) %0.80.7 111.1%  
Book value per share (Unadj.) Rs219.5462.9 47.4%  
Shares outstanding (eoy) m33.0745.75 72.3%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.94.9 59.2%   
Avg P/E ratio x20.944.5 47.0%  
P/CF ratio (eoy) x16.128.6 56.4%  
Price / Book Value ratio x3.04.7 63.3%  
Dividend payout %16.130.8 52.2%   
Avg Mkt Cap Rs m21,50499,163 21.7%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m1,1282,758 40.9%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m7,38920,170 36.6%  
Other income Rs m167857 19.5%   
Total revenues Rs m7,55621,028 35.9%   
Gross profit Rs m1,7934,310 41.6%  
Depreciation Rs m3041,239 24.6%   
Interest Rs m3665 7,042.3%   
Profit before tax Rs m1,2903,923 32.9%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m3091,794 17.2%   
Profit after tax Rs m1,0272,228 46.1%  
Gross profit margin %24.321.4 113.6%  
Effective tax rate %23.945.7 52.3%   
Net profit margin %13.911.0 125.9%  
BALANCE SHEET DATA
Current assets Rs m3,68116,299 22.6%   
Current liabilities Rs m3,1237,594 41.1%   
Net working cap to sales %7.643.2 17.5%  
Current ratio x1.22.1 54.9%  
Inventory Days Days8965 137.1%  
Debtors Days Days5926 227.9%  
Net fixed assets Rs m7,6858,622 89.1%   
Share capital Rs m331458 72.3%   
"Free" reserves Rs m6,67020,722 32.2%   
Net worth Rs m7,25921,180 34.3%   
Long term debt Rs m95525 3,819.6%   
Total assets Rs m11,95729,137 41.0%  
Interest coverage x4.5755.5 0.6%   
Debt to equity ratio x0.10 11,144.9%  
Sales to assets ratio x0.60.7 89.3%   
Return on assets %11.77.7 152.1%  
Return on equity %14.210.5 134.6%  
Return on capital %20.719.0 109.1%  
Exports to sales %39.40.1 66,147.4%   
Imports to sales %5.717.5 32.6%   
Exports (fob) Rs m2,90812 24,231.7%   
Imports (cif) Rs m4213,526 11.9%   
Fx inflow Rs m3,44552 6,670.7%   
Fx outflow Rs m703140 502.1%   
Net fx Rs m2,743-88 -3,104.9%   
CASH FLOW
From Operations Rs m1,4403,436 41.9%  
From Investments Rs m-1,089-6,991 15.6%  
From Financial Activity Rs m-353-619 57.0%  
Net Cashflow Rs m-1-4,174 0.0%  

Share Holding

Indian Promoters % 52.0 0.0 -  
Foreign collaborators % 1.5 63.9 2.3%  
Indian inst/Mut Fund % 7.8 7.5 104.5%  
FIIs % 16.6 4.9 339.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 23.7 109.7%  
Shareholders   25,395 85,207 29.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Share Buybacks, GST Cess on Motor Vehicles, and Top Stocks in Focus Today(Pre-Open)

Indian share markets witnessed buying interest on Wednesday and finished their session in the green for the second straight session. Heavy buying was seen in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 23, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - ALEMBIC LTD COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS